Rakesh Dixit
Company: Regio Biosciences | Bionavigen
Job title: President & Chief Scientific Officer
Seminars:
Unlocking Synergy: Harnessing Bispecific Formats for ADCs to Enhance Targeting and Efficacy 10:00 am
Enhancing targeting precision through bispecific ADC formats enable precise targeting of tumor cells, reducing off-target effects and enhancing therapeutic efficacy Harnessing the power of bispecific ADCs to overcome resistance mechanisms, opening the door to treating challenging or resistant indications Unlocking a broader spectrum of therapeutic possibilities by leveraging bispecific ADCs, providing a versatile platform for…Read more
day: Conference Day One
Safety of Bispecific Antibodies, ADCs and CAR-T cells 1:45 pm
Safety of Bispecific Antibodies, ADCs and CAR-T cells Safety challenges in development of bispecific and CAR-T cells Preclinical models to evaluate safety Challenges to preclinical to clinical translation Mitigating toxicities and improving therapeutic indexRead more
day: Conference Day One - Preclinical/Clinical Track PM